I hope that is the case, interesting it performed better with the lower 50mg dose vs the 75mg against the UMSARS endpoint. Anyone have a view why that might be the case?
All will be revealed this year after they meet with the FDA, and if the FDA recommend AA pathway I think that will be my entry point
should find out mid year
goodluck
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $82.14M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $19.73K | 2.171M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 9715697 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 7264518 | 8 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |